Reading Room

Recommendations for Contraceptive Use

Previous PageTable Of Contents


Combined Injectable Contraceptives


Classification of Selected Procedures for Combined Injectable Contraceptives (CICs)

Procedure Class Rationale
Pelvic examination (speculum and bimanual) C
  • A pelvic exam is not necessary to ensure safe use of injectables as a contraceptive method.
  • In some cases, a pelvic exam may help evaluate the question of pregnancy beyond 6 weeks duration. In this case, it is Class A.
Blood pressure B CICs are not known to modify blood pressure, however due to the estrogen content, World Health Organization (WHO) has included very high blood pressure as an important eligibility criterion1.
Breast examination B CICs do not cause breast cancer. However, if the client has breast cancer, injectables should not be used. WHO considers current breast cancer to be Category 4 for CICs (use of the method with this condition is an unacceptable health risk)1.
Sexually transmitted disease (STD) screening by lab tests (for asymptomatic persons) C Presence of an STD will not affect the safe use of injectables.
Cervical cancer screening C Cervical screening is not needed for the safe use of injectables.
Routine, mandatory lab tests (e.g., cholesterol, glucose, liver function tests) D CICs do not modify cholesterol, glucose or affect the liver function.
Proper infection prevention procedures A Proper infection prevention procedures are important to minimize the risk of infection to clients and providers (see Question 4).
Specific counseling points for CIC use:
  • efficacy
  • common side effects, including alterations in bleeding patterns (e.g., frequent or irregular bleeding, anemia evaluation with heavy bleeding, extended amenorrhea, break-through bleeding)
  • correct use of method (including date of next injection and instructions for late injections)
  • signs and symptoms for which to see a health provider
  • need for STD protection (when/as appropriate)
A
  • Proper counseling is important to ensure informed consent.
  • Appropriate counseling about common contraceptive side effects at the time of method selection can lead to improved client satisfaction and contraceptive continuation.
  • The woman should be encouraged to return if she has any problems or at any time she has questions or concerns.

KEY:

Class A = essential and mandatory or otherwise important in all circumstances, for safe and effective use of the contraceptive method

Class B = medically/epidemiologically rational in some circumstances to optimize the safe and effective use of the contraceptive method, but may not be appropriate for all clients in all settings

Class C = may be appropriate for good preventive health care, but not materially related to safe and effective use of the contraceptive method

Class D = not materially related to either good routine preventive health care or to the safe and effective use of the contraceptive method

Citations for Procedures Table:

  1. World Health Organization. Improving access to quality care in family planning: medical eligibility criteria for contraceptive use. Geneva: WHO, 1996.

Any part of Recommendations for Updating Selected Practices in Contraceptive Use may be reproduced or adapted to meet local needs without prior permission from the TG/CWG Secretariat, provided the TG/CWG is acknowledged and the material is made available free of charge or at cost.


| Home | Family Planning | Maternal & Neonatal Health | Cervical CancerRelated Health Topics
Tools for Trainers
| Reading Room | Related Links | Search ReproLine | Website Tools

Quick Search 

Website design copyright © 1995-2003 by JHPIEGO Corporation. All rights reserved.

Last Updated: 09 Jul 2003

URL: http://www.reproline.jhu.edu/
Reproductive Health Online (ReproLine): a family planning and reproductive health training website

Top Of Page